About Instgra 30 tablets
Experience monumental value with Instgra 30 Tablets, a top-notch antiretroviral therapy designed for the effective management of HIV-1 infection. Manufactured by Emcure Pharmaceuticals Ltd., these FDA-approved, film-coated, pale yellow, oval-shaped tablets feature Dolutegravir Sodium as the active ingredient. Each box contains 30 tablets, ensuring a reliable monthly supply for adults and adolescents (age 12+ and 40 kg). Benefit from this clearance opportunity for an essential, clinically proven treatment. Purchase Instgra with confidence and trust in astonishing therapeutic potential and quality. Prescription required.
Ideal Use and Key Features of Instgra 30 Tablets
Instgra 30 Tablets are suitable for adults and adolescents aged 12 years and older, weighing at least 40 kg, diagnosed with HIV-1 infection. Each tablet includes 50 mg of Dolutegravir, recommended for daily oral administration as directed by your physician. The film-coated, pale yellow, oval-shaped tablets are easy to swallow and offer top-notch efficacy as an integrase strand transfer inhibitor. This monumental treatment is widely used in combination with other antiretroviral agents, providing remarkable support to those undergoing HIV therapy.
Order Availability, Packaging, and Supply Overview
Sample options are available for Instgra 30 Tablets, facilitating confident procurement decisions. The product is packaged securely in an HDPE bottle, containing a month's supply. With impressive supply ability and robust service as an exporter, supplier, and trader across India, order processing is swift and efficient. Orders are carefully processed, packaged, and promptly handed over for distribution within the main domestic market, ensuring an astonishing commitment to quality and readiness for timely delivery.
FAQ's of Instgra 30 tablets:
Q: How should Instgra 30 Tablets be administered for optimal results?
A: Instgra 30 Tablets are administered orally, typically once daily at the dosage prescribed by your healthcare provider. It is important to follow all instructions closely and not to skip or exceed the recommended dose for best therapeutic results.
Q: What are the primary benefits of using Instgra 30 Tablets in HIV therapy?
A: Instgra 30 Tablets, containing Dolutegravir, offer top-notch efficacy in suppressing HIV-1 replication. They are used in combination with other antiretrovirals, helping improve immune function and potentially reducing the risk of HIV progression when taken as prescribed.
Q: When should I avoid taking Instgra 30 Tablets?
A: You should not take Instgra if you have a history of hypersensitivity to Dolutegravir or any component of the product. Always notify your physician of any allergies or previous adverse reactions before starting this medication.
Q: What precautions should be taken regarding drug interactions with Instgra?
A: Instgra may interact with other antiretroviral, antiepileptic, or antacid medications. Inform your doctor about all medicines you are currently taking to avoid unwanted interactions and ensure the effectiveness of your HIV therapy.
Q: Where should Instgra 30 Tablets be stored to maintain their efficacy?
A: Instgra 30 Tablets should be stored below 30C in a dry place, protected from light and moisture, and kept in their original HDPE bottle packaging to preserve their integrity and effectiveness.
Q: What potential side effects should I be aware of when using Instgra?
A: Possible side effects of Instgra include insomnia, headache, nausea, and fatigue. Consult your healthcare provider if you experience any persistent symptoms or have concerns regarding side effects during treatment.